Frequently Asked Questions

​​

1. Can you deliver?

​

Yes, and here’s how we ensure it gets done right.

​

Strategic Growth AI was purpose-built to deliver commercialization through a scalable blend of in-house leadership, AI enablement, integrated services,  fractional experts, and trusted partner collaborators. We focus on delivering outcomes through proven frameworks, deep domain knowledge, and clear execution plans aligned with your goals and budget.

​

Whether it's regulatory strategy, go-to-market execution, AI integration, or interim leadership, we've done it, built systems around it, and deploy fast, without wasting time or resources. If something falls outside our scope, we’ll bring in the right specialist or refer you to someone we trust, so you stay on track. Our reputation is built on delivering what we promise and taking care of our clients like partners, not projects.

​

2. Your service portfolio seems very broad, how do you maintain focus?

​

We understand that a wide range of offerings can feel overwhelming. At Strategic Growth AI, our services were designed through a combination of research and experience to form an integrated, tailorable ecosystem addressing the four critical challenges that most commonly derail life-science, healthcare, and AI ventures which are Leadership & Talent Shortfall, Regulatory & Market-Access Bottlenecks, AI Adoption Misfires and Investor–Founder Disconnect..

 

Our integrated suite solves these concerns through their interaction and inclusion of:

• Regulatory readiness

• Market-access strategy

• Operational execution

• Fractional leadership

 

The services are also tailorable and modular, we/you only deploy what you need, when you need it, so every phase of your commercialization journey is aligned, de-risked, cost-effective and laser-focused on your success.

View Commercial Services

​

3. How much does this cost?

​

Our fees reflect the specialized expertise and execution focus we bring, and because our suite is fully tailorable, you only pay for the services you use. We offer flexible engagement structures fixed-fee projects, monthly retainers, or value-based arrangements—customized to your scope and goals. Once we understand your objectives, we’ll provide a proposal that aligns investment with expected outcomes.

​

4. We already have an in-house team. Why partner with you?

​

That’s great, a strong internal talent is key. We’re here to augment and amplify your capabilities, not replace them. Our founder-led experts and Clarity AI framework provide:

• Deep regulatory and reimbursement insights that most in-house teams don’t maintain full-time

• Proven GTM playbooks and fractional C-suite leadership for targeted initiatives

• Objective, data-driven validation and optimization of your existing strategies

​​

Think of us as a force multiplier, filling niche expertise gaps and accelerating your progress.

​

5. How quickly can we expect tangible results?

​

Timelines vary by scope, but we prioritize rapid, measurable impact:

• 30–90-day “Commercialization Sprints” deliver clear milestones (e.g., refined market-access plan, initial regulatory roadmap, pilot AI insights)

• Regulatory engagements often reduce approval cycles by months

• AI implementations focus on early ROI, with pilot metrics in weeks

From day one, we set KPIs and reporting cadences so you see progress in real time.

​

6. What makes Clarity AI different?

​

Clarity AI is our proprietary, sector-specific intelligence workflow. Unlike generic LLMs, it’s trained on:

• Regulatory guidelines (FDA, Health Canada, EMA)

• Real-world evidence and payer-engagement data

• Commercialization benchmarks in life sciences and healthcare

It acts as an expert co-pilot, surfacing critical insights, flagging compliance risks, and accelerating your decisions in ways off-the-shelf tools can’t.

​

View Clarity AI

​

7. How do you ensure compliance and minimize regulatory risk?

​

Compliance is foundational. We embed regulatory rigor into every engagement by:

1. Gap analyses against current guidelines

2. Submission-ready strategies and dossier support

3. Built-in Clarity AI intelligence 

4. Post-approval planning to streamline launch and scale​

​

8. What’s included in the 30-Day Sprint?

​

Our 30-Day Sprint is a high-impact commercialization engagement designed to compress 6+ months of strategy into 4 weeks. You get:

•  Investor-Ready Positioning: Align story, metrics, and risk strategy

• Regulatory & GTM Map: Clear steps for approval and market access

• Sales Strategy & Outreach Assets: Messaging + targeting plan

• Clarity AI™ Diagnostic: Identify execution gaps and resource needs

• Weekly Working Sessions: With commercial, regulatory, and AI experts

• Final Sprint Briefing: Custom roadmap with validated next steps

You walk away with clarity, confidence, and a credible launch path investors trust.

​

9. Do you help with both AI and traditional life science ventures?

​

Yes. Strategic Growth AI was built to bridge the gap between deep tech and life sciences.

We work with:

• Traditional life sciences (biotech, pharma, medtech, diagnostics) needing commercial, regulatory, and GTM expertise

• AI-health and digital health startups struggling with adoption, evidence, and provider alignment

 

Whether you're navigating SaMD approval or launching a specialty drug, we bring the right experts and execution frameworks to move you faster and smarter.

​

10. What stage of company do you typically work with?

We support ventures from Seed to Series C, SMB and enterprise teams launching new products, divisions or entering regulated markets and VC, PE and Angels. If you're preparing for market entry, fundraising, regulatory approval, or scaling post-approval, we're built for you.

​

11. Can you help us prepare for investors or a funding round?

Yes. We specialize in investor readiness, including:

• Risk-adjusted storytelling

• Regulatory roadmaps investors trust

• Commercial potential validation

• Data room prep

• Executive coaching for Q&A and diligence

​​

Our 30-Day Sprint and Clarity AI™ system are often used by founders preparing for Seed, Series A, Series B and Series C raises.

 

12. Do you work with global companies entering Canada or the U.S.?

Absolutely. We've helped European, APAC, and LATAM companies navigate North American market entry, including:

• Regulatory approvals (FDA, Health Canada)

• Market access and reimbursement strategy

• Clinical and KOL engagement

• Localization of GTM materials and commercial plans

 

13. Do you take equity or offer venture studio-style partnerships?

In select cases, yes. For high-potential companies that align with our mission, we offer hybrid models that may include:

• Equity-for-services

• Joint ventures

• Revenue-sharing commercialization agreements
  We’re open to structured discussions based on strategic alignment.

 

14. Are your consultants industry veterans or generalists?

We don’t use generalists. Every engagement is led by domain experts with deep experience in:

• Biotech, pharma, medtech

• AI/ML healthcare tools

• Regulatory agencies and payer systems

• Launching and scaling health ventures

We augment with fractional leadership or partners only when their expertise meets your exact needs.

 

15. What industries or products do you not support?

We don’t typically work with:

• Consumer-facing wellness apps without clinical or regulatory relevance

• Pre-seed ventures with no market validation

• Companies without a clear problem-solution fit or team to execute

 

Our model works best where a strong innovation needs commercial clarity and strategic execution.

 

16. What do you need from us to get started?

Before kickoff, we’ll request:

• A short discovery call

• Any relevant decks, data, or regulatory history

• Your 1–3 priority goals for the next 90 days
  From there, we’ll shape a proposal or sprint roadmap within 5 business days.

​​

17. Do you help with product development or just commercialization?
 

We assist with product market fit and focus on late-stage development through launch and scale, not preclinical R&D. However, we frequently help refine:

• Clinical positioning

• Value-based design

• Evidence strategy for reimbursement

• Post-market product evolution

We ensure your product aligns with what the market (and regulators) actually require.

​

18. Do you work with hospitals, public health, or nonprofits?

Yes, when the mandate is innovation, commercialization, therapeutic support, new product entry or AI adoption. We support hospital-based startups, research groups, and provincial health collaborations focused on scalable impact, not academic theory.

​

19. How is your work different from a traditional consulting firm?

Strategic Growth AI is a Strategic Commercialization Solutions company which has been purpose-built for healthcare, AI, and life sciences commercialization. We are commercial operators with a modular, tailored, and execution-focused model that blends the best of expert consulting, AI-driven execution, and embedded leadership.

we provide:

• AI-enhanced workflows

• Clarity AI™

• Regulatory + GTM sprints

• Fractional leadership

• Grant & investor readiness

• Training modules and more

​

20. What is SGAI Academy, and who is it for?

​

SGAI Academy is the executive training division of Strategic Growth AI, built for founders, investors, enterprise teams, and public sector leaders navigating healthcare, life sciences, and AI innovation.

​

It delivers practical, real-world training, not theory, through formats designed for busy professionals:

• 45-minute executive briefings on commercialization, regulatory strategy, AI adoption, and GTM

• YouTube Learning Shorts (launching August 2025) with 30-second strategies and 3-minute tutorials

• Toolkits and frameworks grounded in real launches and investor-backed ventures

• Optional certifications, cohort-based workshops, and case-based learning

 

Whether you're:

• a founder preparing to raise capital or scale

• an investor needing better portfolio alignment and risk visibility

• an enterprise team adopting AI or launching new health solutions

• a government or public sector leader funding innovation or building internal capacity

 

SGAI Academy gives you the clarity, tools, and confidence to lead through complexity.

​

21. How does Clarity AI™ work and what makes it different?

Clarity AI™ is our proprietary, human-in-the-loop (HITL) framework that fuses domain expertise with curated AI tools to support faster, smarter commercialization. It deconstructs complex go-to-market paths using real-time market signals, investor-grade forecasts, and regulatory checklists. Unlike off-the-shelf AI platforms, Clarity AI™ is operator-built and execution-focused—designed to reduce time to market, minimize risk by up to 60%, and deliver tangible traction.

 

22. What pricing models do you offer, and do you commit to outcomes?

We offer flexible pricing models aligned with client needs—ranging from fixed-fee sprints and monthly retainers to milestone-based engagements. For qualified projects, we offer outcome-based deliverables tied to clear commercial metrics (e.g., market access, funding readiness, or regulatory progress). This ensures we’re aligned not just on effort, but on results.

 

23. What timelines should we expect for commercialization or AI implementation?

Our 30-Day Commercialization Sprint delivers a strategic foundation, GTM plan, and investor-aligned roadmap within 4–6 weeks. Full execution timelines range from 60 to 180 days depending on complexity, regulatory needs, and sales cycles. For AI implementation, use-case deployment typically begins within 2–4 weeks, with optimization over a 90-day horizon.

​

24. Who are your ideal clients?

StrategicGrowthAI serves four key client segments across life sciences, healthcare, and AI-health:

• Startups (Pre-Seed to Series B): Especially in biotech, medtech, diagnostics, or AI-health, seeking fast, de-risked market entry, fundraising support, or regulatory navigation.

• SMBs (Series B+ and mid-market): Commercial-stage companies looking to scale efficiently, accelerate sales, implement AI, or plug leadership gaps without expanding internal headcount.

• Enterprises: Innovation, regulatory, or digital transformation teams needing outside execution horsepower, fractional execs, or AI integration for high-impact strategic projects.

• Investors & Accelerators: VC, PE, and government-backed organizations supporting portfolio companies through commercialization, value inflection, and non-dilutive acceleration.

​